Eiger BioPharmaceuticals, Inc. filed a notice for the selection of Successful Bidder in the US Bankruptcy Court for the sale of its substantially all its assets on April 19, 2024. As a result of the auction conducted on April 17, 2024, Sentynl Therapeutics, Inc., has been selected as the winning bidder for the sale of debtor?s substantially all its assets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | 0.00% | +4.55% | -65.85% |
1st Jan change | Capi. | |
---|---|---|
-65.85% | 3.41M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.19% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Selection of Successful Bidder Filed by Eiger BioPharmaceuticals, Inc.